Trial
NCT00240981
TOM: Testosterone in Older Men With Sarcopenia
Phase IVTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Boston Medical Center
Collaborators
National Institute on Aging (NIA)
Condition
Sarcopenia
Intervention
Topical testosterone gel 1% (active formulation)
Why stopped
Higher incidence of cardiovascular events in the testosterone arm of the trial. Decision taken by the DSMB on December 31st, 2009.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-23